Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    Pricing Plans    |    Today's News    |    News By Category    |    News By Region    |    News By Date    |    Business Directory    |    Private Branding
All Press Releases for January 07, 2009 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



Wound-Be-Gone : New Product Set Standard of Care for Non-Healing Sores
Effective and inexpensive treatment prevents complications associated with chronic wounds. 
x-small text small text medium text large text


    BELLWOOD, IL, January 07, 2009 /24-7PressRelease/ -- Wound-Be-Gone (http://www.woundbegone.com/), lead product offering from Wake Pharm US, is now available and is changing the way people treat chronic, non-healing wounds. Inexpensive yet very effective, Wound-Be-Gone and its patented free radical binding technology is putting wound care into the hands of people who might otherwise suffer or whose wound problems might escalate until they need expensive medical interventions.

Complications from chronic, complex non-healing wounds can be dire. Not only can they lead to infection and pain, they lead to depression and even limb amputation. Patients affected by these types of wounds often require additional help performing common daily tasks and face higher mortality rates. Wound-Be-Gone is useful beyond simple wound care.

Literally millions of Americans seek relief each year as complex non-healing wounds are associated with diabetes, pressure ulcers, venous ulcers and non-healing postoperative wounds. Everyone needs access to the "best standard" of care to heal chronic wounds. The new over the counter product Wound-Be-Gone promises to significantly reduce the overall costs for treating wounds, and restore quality of life.

Damian Styga, Sales/Marketing Executive stated that Wake Pharm US points out many dimensions that treating acute and chronic wounds represents a significant financial burden on people and on the health care system. "Expenses related to wound care may include surgical and diagnostic procedures, pharmaceuticals, fees for services provided by physicians and other health care professionals," he said. "Other costs include the use of medical equipment, the use of devices to provide compression or support for surfaces, wound closing, and the cost of skin care protection products, compression bandages, and changing dressings."

Wake Pharm US, Inc encourages the adoption of cost-effective wound-healing approaches for acute and chronic wounds management.

Wound-Be-Gone is a breakthrough invention for treating acute and chronic wounds. It works using a patented, revolutionary principle, and is totally different from current healing products. It helps the wound fully heal.

Some of conventional medical treatment work well for the early stage of healing but are not designed to see healing through. While they are fine for the inflammation stage, they don't help the wound cover up with new skin. So while treatment of the wound may occur, healing does not.

Wound-Be-Gone offers a unique combination of the most modern treatments for "moist healing" together with a patented active ingredient developed by the Institute of Macromolecular Chemistry Academy of Sciences of the Czech Republic.

The moist environment supports the movement of cells in the wound and maintains constant temperature in the wound, which is critical for quick healing without unsightly scars. The active ingredient removes free oxygen radicals from the site of the wound, while at the same time creating an elastic layer that prohibits contact between the wound and its external environment. This prevents infection and accelerates healing process.


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #

Press Release Keywords:
Other Press Release Headlines:

Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Press Release Contact Information:
Damian Styga
Wake Pharm US

Sales/Marketing Executive
2837 Washington Blvd
Bellwood, IL
US 60104
Voice: 7085449021
Fax: 7085449029
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.